Literature DB >> 15446582

Gene expression profiles of reactive astrocytes in dopamine-depleted striatum.

Takao Nakagawa1, Joan P Schwartz.   

Abstract

We have used cDNA array analysis to examine the expression of genes in reactive astrocytes of dopamine-depleted striatum of rats in vivo, an animal model for Parkinson disease, compared to those from control striatum. The striatum of both normal adult rats and rats whose substantia nigra had been lesioned with 6-hydroxydopamine was removed one week following lesion. After fixing the tissue in RNAlater, individual astrocytes, isolated directly from dissociated striatum and confirmed to be astocytes by expression of glial fibrillary acidic protein (GFAP) mRNA using single cell RT-PCR, were used as the source of mRNA. Co-localization of GFAP with either of 2 antibodies known to label only reactive astrocytes in vivo confirmed that virtually all astrocytes in the lesioned striatum were reactive. The analysis has identified 29 genes whose expression is turned on or enhanced in dopamine-depleted striatal astrocytes and 2 whose expression is decreased. In situ hybridization was used to confirm the localization of 8 of these genes to astrocytes: these included GDNF, NGF, bFGF, TNF-alpha, MIP-1alpha, c-jun, Fra-1 and Fra-2. Understanding these gene differences that occur in astrocytes in response to dopamine depletion should enhance our ability to promote recovery from the injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15446582     DOI: 10.1111/j.1750-3639.2004.tb00064.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  19 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.

Authors:  Takao Nakagawa; Toshihiko Kubota; Kazunori Ido; Takahiro Sakuma; Ken Matsuda
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

3.  Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.

Authors:  Anja Drinkut; Yuliya Tereshchenko; Jörg B Schulz; Mathias Bähr; Sebastian Kügler
Journal:  Mol Ther       Date:  2011-11-15       Impact factor: 11.454

4.  Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.

Authors:  Bokyung Park; Chang-Ki Oh; Won-Seok Choi; In Kwon Chung; Moussa B H Youdim; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

5.  TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.

Authors:  Jin H Nam; Eun S Park; So-Yoon Won; Yu A Lee; Kyoung I Kim; Jae Y Jeong; Jeong Y Baek; Eun J Cho; Minyoung Jin; Young C Chung; Byoung D Lee; Sung Hyun Kim; Eung-Gook Kim; Kyunghee Byun; Bonghee Lee; Dong Ho Woo; C Justin Lee; Sang R Kim; Eugene Bok; Yoon-Seong Kim; Tae-Beom Ahn; Hyuk Wan Ko; Saurav Brahmachari; Olga Pletinkova; Juan C Troconso; Valina L Dawson; Ted M Dawson; Byung K Jin
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

6.  Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway.

Authors:  David M Yurek; Anita M Fletcher; Laura E Peters; Wayne A Cass
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 7.  "Targeting astrocytes in CNS injury and disease: A translational research approach".

Authors:  Angela R Filous; Jerry Silver
Journal:  Prog Neurobiol       Date:  2016-03-26       Impact factor: 11.685

8.  Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway.

Authors:  Ana Gadea; Sergio Schinelli; Vittorio Gallo
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

9.  Testing alternatives: the use of adipose-derived mesenchymal stem cells to slow neurodegeneration in a rat model of Parkinson's disease.

Authors:  Fatma Y Meligy; Dalia A Elgamal; Eman S H Abd Allah; Naglaa K Idriss; Nagwa M Ghandour; Ehab M R Bayoumy; Azza Sayed Abdelrehim Khalil; Mohamed M El Fiky; Mostafa Elkhashab
Journal:  Mol Biol Rep       Date:  2019-08-08       Impact factor: 2.316

10.  Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.

Authors:  Nga-Ping Lui; Liang-Wei Chen; Wing-Ho Yung; Ying-Shing Chan; Ken Kin-Lam Yung
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.